Dr. Friba Nurmukhamma | Medicine | Best Researcher Award

Khoja Akhmet Yassawi International Kazakh-Turkish University | Kazakhstan

Dr. Friba NurmukhammadNasrullakyzy is a cardiologist, senior researcher, and PhD scholar specializing in cardiovascular pathology, with a particular focus on coronary artery disease (CAD), stenting, and post-coronary artery bypass grafting (CABG) outcomes. Her research explores the mechanisms of high residual platelet reactivity (HRPR) and dyslipidemia, contributing to improved treatment algorithms and predictive models aimed at reducing mortality in patients with complex cardiovascular conditions. Dr. Friba’s innovative work integrates clinical insights with advanced diagnostic methodologies and personalized therapeutic approaches, emphasizing non-statin therapies, platelet reactivity modulation, and functional diagnostics in cardiology. She has authored multiple peer-reviewed publications indexed in Scopus and other scientific databases, reflecting a growing international research presence. Her Scopus h-index is 3, and her research impact is further supported by citations across both Scopus and Google Scholar databases. Dr. Friba’s current projects involve developing mortality prediction scales and individualized treatment algorithms for patients with HRPR, aiming to advance precision medicine in cardiology. Her scientific contributions underscore her commitment to translational cardiovascular research and her role in fostering evidence-based practices within clinical cardiology.

Profile

Scopus | ORCID

Featured Publications

Mussagaliyeva, A., Zhangelova, S., Danyarova, L., Nurmukhammad, F., Kapsultanova, D., Sakhov, O., Rustamova, F., Sugraliyev, A., & Akhmentayeva, D. (2025). Residual platelet reactivity and dyslipidemia in post-CABG patients undergoing repeat revascularization: Insights from Kazakhstan. Diseases, 13(11), 365.

Nurmukhammad, F. N., Zhangelova, S. B., & Kapsultanova, D. A. (2025). Non-statin therapy in patients with elevated LDL-C and high platelet reactivity: A narrative review. Medical Journal of Malaysia, 80(2), 258–265.

Zhangelova, S. B., Nurmukhammad, F. N., & Nurdinov, N. (2023). High residual platelet reactivity as a predictor of atherothrombosis in patients with coronary heart disease. Science and Healthcare, 25(3), 25–31.

Mussagaliyeva, A., Zhangelova, S., Nurmukhammad, F., & Kapsultanova, D. (2025). Residual platelet reactivity and dyslipidemia in post-CABG patients: Preprint insights from Kazakhstan. Preprints, 2025(09), 2498.

Dr. Shao Guang Liu | Medicine | Best Researcher Award

Dr. Shao Guang Liu | Associate Professor | Gansu Provincial Hospital | China

Dr. Liushaoguang is an accomplished associate professor and clinical expert in trauma and emergency medicine, currently contributing to the advancement of medical research and patient care at Gansu Provincial Hospital. His research primarily focuses on emergency trauma management and sepsis-induced peritonitis, with a strong emphasis on molecular and immunological mechanisms underlying trauma-related complications. Dr. Liushaoguang has led and completed several significant provincial-level projects, including studies on the construction of trauma care system management models and investigations into dendritic cell function transformation and immune paralysis in sepsis. His scholarly contributions reflect a deep integration of clinical insight and biomedical research aimed at improving critical care outcomes. His work has been widely recognized in academic circles, with a citation record of 160 citations across 11 documents and an h-index of 6 on Scopus, demonstrating the impactful nature of his research. On Google Scholar, his publications have also garnered substantial attention from the scientific community. In addition to his research achievements, Dr. Liushaoguang serves on the editorial board of the Chinese Journal of Traumatology, further underscoring his commitment to advancing medical knowledge. His published works explore various aspects of sepsis, endothelial function, gene methylation, and circular RNA mechanisms in inflammatory responses.

Profile

Scopus

Featured Publications

Liushaoguang. (2023). Four differentially methylated gene pairs to predict the prognosis for early stage. Frontiers in Genetics.
Liushaoguang. (2023). Circular RNA circ_0001105 protects the intestinal barrier of septic rats by inhibiting inflammation. BMC Gastroenterology.
Liushaoguang. (2022). Transcriptomics changes in the peritoneum of mice with lipopolysaccharide-induced peritonitis. Scientific Reports.
Liushaoguang. (2022). Endothelial progenitor cell-derived exosomal miRNA-31 alleviates septic peritonitis. Cell Death Discovery.
Liushaoguang. (2021). Research on the construction of the trauma care system management model in Gansu Province. Chinese Journal of Traumatology.